CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 100 of 110 entries

View as:

Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.

Phase: N/A Priority: Normal

NCT ID: NCT04038710 Org: User:

Start: 09/05/19 End: 02/26/21 Due: 02/26/22

FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults

Phase: N/A Priority: Normal

NCT ID: NCT01950494 Org: User:

Start: 09/30/13 End: 07/31/14 Due: 07/31/15

Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT00692796 Org: User:

Start: 04/30/08 End: 03/31/10 Due: 03/31/11

The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal

NCT ID: NCT00238082 Org: User:

Start: 11/30/99 End: 02/28/05 Due: 02/28/06

Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)

Phase: N/A Priority: Normal

NCT ID: NCT02323100 Org: User:

Start: 12/02/18 End: 03/01/22 Due: 03/01/23

PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT02073409 Org: User:

Start: 12/31/13 End: 03/31/25 Due: 03/31/26

T Cell Memory Fuels the Innate Response in Chronic CF Lung Disease

Phase: N/A Priority: Normal

NCT ID: NCT04397861 Org: User:

Start: 05/06/15 End: 11/01/21 Due: 11/01/22

Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen

Phase: N/A Priority: Normal

NCT ID: NCT00738569 Org: User:

Start: 07/31/08 End: 02/28/11 Due: 02/28/12

Creation of Home-based Asthma Real-World Measures With Mobile Health Study

Phase: N/A Priority: Normal

NCT ID: NCT04462224 Org: User:

Start: 01/11/21 End: 07/01/23 Due: 07/01/24

Alveolar Macrophage Programming Following Endotoxin Exposure

Phase: N/A Priority: Normal

NCT ID: NCT03859050 Org: User:

Start: 03/18/19 End: 07/31/32 Due: 07/31/33

Telehealth Cognitive Behavioral Stress Management for Adults With Cystic Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT03560726 Org: User:

Start: 06/04/18 End: 06/01/20 Due: 06/01/21

Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

Phase: N/A Priority: Normal

NCT ID: NCT02947945 Org: User:

Start: 09/12/17 End: 12/31/18 Due: 12/31/19

Tailored Treatment to Enhance Risk Perception in Sleep Apnea

Phase: N/A Priority: Normal

NCT ID: NCT02314858 Org: User:

Start: 10/01/14 End: 03/31/21 Due: 03/31/22

Targeting Oxidative Stress in Chronic Beryllium Disease

Phase: N/A Priority: Normal

NCT ID: NCT01088243 Org: User:

Start: 03/31/10 End: 03/31/15 Due: 03/31/16

An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation

Phase: N/A Priority: Normal

NCT ID: NCT03377647 Org: User:

Start: 08/01/17 End: 06/30/25 Due: 06/30/26

Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF

Phase: N/A Priority: Normal

NCT ID: NCT02626182 Org: User:

Start: 12/31/15 End: 01/29/18 Due: 01/29/19

Hand Sanitizer Effects on the Skin Barrier

Phase: N/A Priority: Normal

NCT ID: NCT04525521 Org: User:

Start: 12/01/20 End: 08/20/21 Due: 08/20/22

Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)

Phase: N/A Priority: Normal

NCT ID: NCT06155747 Org: User:

Start: 03/01/23 End: 02/28/28 Due: 02/28/29

Progression of Airway Obstruction in Childhood Asthma

Phase: N/A Priority: Normal

NCT ID: NCT00873873 Org: User:

Start: 09/30/08 End: 06/30/11 Due: 06/30/12

Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease

Phase: N/A Priority: Normal

NCT ID: NCT00659529 Org: User:

Start: 08/31/08 End: 12/31/12 Due: 12/31/13

COVID-19 Vaccine Response in Chronic Respiratory Conditions

Phase: N/A Priority: Normal

NCT ID: NCT05313087 Org: User:

Start: 02/03/21 End: 12/30/24 Due: 12/30/25

Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution

Phase: N/A Priority: Normal

NCT ID: NCT01736839 Org: User:

Start: 11/30/12 End: 07/27/17 Due: 07/27/18

Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT01107028 Org: User:

Start: 02/28/10 End: 10/31/14 Due: 10/31/15

Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)

Phase: N/A Priority: Normal

NCT ID: NCT04261582 Org: User:

Start: 11/06/18 End: 04/30/22 Due: 04/30/23

Cell Biology of Steroid Resistant Asthma

Phase: N/A Priority: Normal

NCT ID: NCT00361920 Org: User:

Start: 08/31/06 End: 03/31/07 Due: 03/31/08

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.	NCT04038710	National Jewish Health	user2@example.com	None	2019-09-05	2021-02-26	2022-02-26	-	-	2025-07-14
FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults	NCT01950494	National Jewish Health	user2@example.com	None	2013-09-30	2014-07-31	2015-07-31	-	-	2025-07-14
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis	NCT00692796	National Jewish Health	user2@example.com	None	2008-04-30	2010-03-31	2011-03-31	-	-	2025-07-14
The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease	NCT00238082	National Jewish Health	user2@example.com	None	1999-11-30	2005-02-28	2006-02-28	-	-	2025-07-14
Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)	NCT02323100	National Jewish Health	user2@example.com	None	2018-12-02	2022-03-01	2023-03-01	-	-	2025-07-14
PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis	NCT02073409	National Jewish Health	user2@example.com	None	2013-12-31	2025-03-31	2026-03-31	-	-	2025-07-14
T Cell Memory Fuels the Innate Response in Chronic CF Lung Disease	NCT04397861	National Jewish Health	user2@example.com	None	2015-05-06	2021-11-01	2022-11-01	-	-	2025-07-14
Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen	NCT00738569	National Jewish Health	user2@example.com	None	2008-07-31	2011-02-28	2012-02-28	-	-	2025-07-14
Creation of Home-based Asthma Real-World Measures With Mobile Health Study	NCT04462224	National Jewish Health	user2@example.com	None	2021-01-11	2023-07-01	2024-07-01	-	-	2025-07-14
Alveolar Macrophage Programming Following Endotoxin Exposure	NCT03859050	National Jewish Health	user2@example.com	None	2019-03-18	2032-07-31	2033-07-31	-	-	2025-07-14
Telehealth Cognitive Behavioral Stress Management for Adults With Cystic Fibrosis	NCT03560726	National Jewish Health	user2@example.com	None	2018-06-04	2020-06-01	2021-06-01	-	-	2025-07-14
Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study	NCT02947945	National Jewish Health	user2@example.com	None	2017-09-12	2018-12-31	2019-12-31	-	-	2025-07-14
Tailored Treatment to Enhance Risk Perception in Sleep Apnea	NCT02314858	National Jewish Health	user2@example.com	None	2014-10-01	2021-03-31	2022-03-31	-	-	2025-07-14
Targeting Oxidative Stress in Chronic Beryllium Disease	NCT01088243	National Jewish Health	user2@example.com	None	2010-03-31	2015-03-31	2016-03-31	-	-	2025-07-14
An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation	NCT03377647	National Jewish Health	user2@example.com	None	2017-08-01	2025-06-30	2026-06-30	-	-	2025-07-14
Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF	NCT02626182	National Jewish Health	user2@example.com	None	2015-12-31	2018-01-29	2019-01-29	-	-	2025-07-14
Hand Sanitizer Effects on the Skin Barrier	NCT04525521	National Jewish Health	user2@example.com	None	2020-12-01	2021-08-20	2022-08-20	-	-	2025-07-14
Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)	NCT06155747	National Jewish Health	user2@example.com	None	2023-03-01	2028-02-28	2029-02-28	-	-	2025-07-14
Progression of Airway Obstruction in Childhood Asthma	NCT00873873	National Jewish Health	user2@example.com	None	2008-09-30	2011-06-30	2012-06-30	-	-	2025-07-14
Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease	NCT00659529	National Jewish Health	user2@example.com	None	2008-08-31	2012-12-31	2013-12-31	-	-	2025-07-14
COVID-19 Vaccine Response in Chronic Respiratory Conditions	NCT05313087	National Jewish Health	user2@example.com	None	2021-02-03	2024-12-30	2025-12-30	-	-	2025-07-14
Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution	NCT01736839	National Jewish Health	user2@example.com	None	2012-11-30	2017-07-27	2018-07-27	-	-	2025-07-14
Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis	NCT01107028	National Jewish Health	user2@example.com	None	2010-02-28	2014-10-31	2015-10-31	-	-	2025-07-14
Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)	NCT04261582	National Jewish Health	user2@example.com	None	2018-11-06	2022-04-30	2023-04-30	-	-	2025-07-14
Cell Biology of Steroid Resistant Asthma	NCT00361920	National Jewish Health	user2@example.com	None	2006-08-31	2007-03-31	2008-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance